FindTrial
Sign In

Patient test to prove the efficacy and safety of the product Debriderm Fluid, a liquid solution intended for wound dressing preparation

Single-blind clinical study on the efficacy and safety of the product Debriderm Fluid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9zrckqx
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-03-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degloving Injuries

Interventions

This is a study aimed at proving the efficacy and safety of the product Debriderm Fluid, a liquid solution intended for wound dressing preparation. The study was conducted on a single group, clinical
E05.940.790.500

Sponsors

Instituto de Saúde e Bem Estar da Mulher
Lead Sponsor
Nipo Serviços Médicos SS Ltda
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The participating patient has a wound, lesion, or ulcer. The injury requires dressings. Age between 18 and 90 years. Any ethnicity, color/race, and skin phototype. Both genders. Patients are in the early stages of treatment

Exclusion criteria

Exclusion criteria: Pregnancy. Neonates. Sensitivity to the medication components

Design outcomes

Primary

MeasureTime frame
Assess the efficacy and safety of Debriderm Fluid product; it is safe for wound cleansing—

Secondary

MeasureTime frame
Assess the occurrence of necrosis in the area exposed to the product—

Countries

Brazil

Contacts

Public ContactFrederico Viana

TCI Laboratório Biotecnológico Ltda

frederico@tcilab.com.br+55 38 99886-3565

Outcome results

None listed

Source: REBEC (via WHO ICTRP)